A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
W Ling, D R Wesson, C Charuvastra...
https://pubmed.ncbi.nlm.nih.gov/8624183Completed
Phase 3
Age: 21Years - 50Years
All Genders
ID00000205
Buprenorphine Maintenance Protocol
Led by University of California, Los Angeles · Updated on 2016-07-11
N/A
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
Sponsors
U
University of California, Los Angeles
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to compare the efficacy of buprenorphine versus methadone.
CONDITIONS
Official Title
Buprenorphine Maintenance Protocol - 1
Who Can Participate
Age: 21Years - 50Years
All Genders
Eligibility Criteria
You may qualify if you...
M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Self-reported use within the last 30 days. Agreeable to conditions of study and signed informed consent.
You will not qualify if you...
Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and /or nursing women. Dependence on ETOH or benzodiazepines or other sedative/hynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe
Trial Site Locations
Total: 1 location
1
Friends Research Institute
Los Angeles, California, United States, 90025
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
P A Compton, W Ling, V C Charuvastra...
https://pubmed.ncbi.nlm.nih.gov/8555282Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed?
P A Compton, W Ling, D R Wesson...
https://pubmed.ncbi.nlm.nih.gov/8704003